ResMedvs.Zimmer Biomet
RMD vs ZBH · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices, from surgery and cardiology to robotics.
ResMed is about 1.9× larger than Zimmer Biomet by market cap; year to date, Zimmer Biomet leads (−1.2% vs −5.9%).
Side by side
| RMD | ZBH | |
|---|---|---|
| Market cap | $32.1B | $17.4B |
| Price | $230.05 | $89.14 |
| Today | +1.5% | +0.3% |
| Return YTD | −5.9% | −1.2% |
| Return 1Y | −19.7% | −9.6% |
| Since June 26, 2026 | +14.9% | −4.3% |
| P/E | 21.1 | 21.5 |
| P/S | 5.7 | 2.0 |
| P/B | 4.9 | 1.4 |
Data as of 2026-10-09 · updates daily after U.S. close
Since June 26, 2026: the change in the closing price, from the daily closes Sectivia records itself since that date.
The two companies
ResMedRMD
CPAP machines and masks for sleep apnea, sold with cloud software, next to a wider respiratory equipment range.
Full RMD profile →More RMD & ZBH comparisons
Other head-to-heads in the Medtech & devices segment.
See where RMD and ZBH sit in the full Medicine, pharma & life science map: every segment from suppliers to end markets.Open the Life science value chain →